News
Business
Economy
Politics
Technology
Environment
Search
Saturday, November 16, 2024
No menu items!
News
Business
Economy
Politics
Technology
Environment
Search
Home
New GSK maintains strong start, but Zantac litigation looms large
FILE PHOTO: A box and vials of the drug Shingrix,
FILE PHOTO: A box and vials of the drug Shingrix,
FILE PHOTO: A box and vials of the drug Shingrix, made by GlaxoSmithKline Pharmaceutical, sit on a counter at a pharmacy in Provo, Utah, U.S. January 9, 2020. REUTERS/George Frey/File Photo
- Advertisment -
Most Read
How Trump’s Pentagon pick Hegseth fell out of love with the U.S. military
November 15, 2024
Palantir shares rally to fresh record on plans for move to Nasdaq
November 15, 2024
EV companies, battery makers urge Trump not to kill vehicle tax credits
November 15, 2024
Musk expands lawsuit against OpenAI, adding Microsoft and antitrust claims
November 15, 2024
We use cookies to ensure that we give you the best experience on our website.
Ok